Company
Nurix Therapeutics, Inc.
NRIX · CIK 0001549595
Acquisition (code M) of 5,787 shares at $8.72 per share.
Reporting Person Ring Christine · Officer Title Chief Legal Officer · Transaction Code M
Traded Sep 2, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0001817199-26-000030 · filed 2026-09-02 · View filing →
Sale of 5,387 shares at $25.6947 per share.
Reporting Person Ring Christine · Officer Title Chief Legal Officer · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0001817199-26-000030 · filed 2026-09-02 · View filing →
Sale of 400 shares at $26.6375 per share.
Reporting Person Ring Christine · Officer Title Chief Legal Officer · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0001817199-26-000030 · filed 2026-09-02 · View filing →
Acquisition (code M) of 1,452 shares at $1.86 per share.
Reporting Person Hansen Gwenn · Officer Title Chief Scientific Officer · Transaction Code M
Traded Sep 1, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001817160-26-000019 · filed 2026-09-01 · View filing →
Sale of 1,452 shares at $25.47 per share.
Reporting Person Hansen Gwenn · Officer Title Chief Scientific Officer · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001817160-26-000019 · filed 2026-09-01 · View filing →